Location: Home
  • search
  • go
  • Relate News
  • 3/24/2025AstraZeneca Announces $2.5B Investment in China
  • 3/24/2025Syneron Bio Announces Strategic Collaboration with AstraZeneca
  • 3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
  • 3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...
  • 3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...
  • 3/24/2025CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template
  • 3/24/2025China Sets Ambitious Nutritional Targets for 2030 to Improve National ...
  • 3/24/2025Heng Ren Partners Calls for $8.9B Cash Distribution from Sinovac and ...
  • 3/21/2025Forward Pharma Secures CNY 100M Financing
  • 3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint
  • 3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...
  • 3/21/2025Rhythm Pharma Regains Rights to Obesity Drug in China
  • 3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...
  • 3/21/2025CDE Solicits Comments on Chinese Translation of ICH E6 (R3) GCP Guidel...
  • 3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...
  • 3/21/2025NHC Vice-Minister Meets with CEO of Belgian Biopharma Firm UCB
  • 3/21/2025NHSA Releases Its 2024 Statistical Bulletin on Healthcare Security De...
  • 3/21/2025Gilead's Trodelvy Receives Second Approval in China
  • 3/21/2025AZ's Calquence (Acalabrutinib) Receives New Approval in China for Firs...
  • 3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials
  • 3/21/2025Junshi's Toripalimab Receives 11th Approval in China
  • 3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China
  • 3/21/2025Recent Executive Moves
  • 3/21/2025Visen Pharma Debuts on Hong Kong Stock Exchange
  • 3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China
  • 3/20/2025NMPA Seeks Public Feedback on Draft Guidelines for Drug Trial Data Pro...
  • 3/20/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (92...
  • 3/20/2025Chinese Government Issues Notice on Strengthening Drug Traceability Co...
  • 3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...
  • 3/19/2025Accropeutics Secured $12M in Series B Plus Financing
  • Page:15/771 Total number of articles:23121: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group